BiomX holds special shareholder meeting with 36.9% of shares represented

BiomX held a special shareholder meeting on Aug. 25, 2026.

• Shareholders authorized share issuance to Mandragola tied to acquiring controlling equity interests in Dr. Frucht Systems.
• The vote approved a potential reverse stock split within one year, allowing a 1-for-5 to 1-for-20 ratio.
• The reverse-split amendment also permits cutting authorized common shares to 150,000,000 if implemented.
• Barzily & Co. was ratified as independent registered public accounting firm for fiscal 2026; an adjournment proposal also passed.